- Home
- GVH vs CING Comparison
GVH vs CING Comparison
Compare GVH & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- CING
- Stock Information
- Founded
- GVH 2016
- CING 2012
- Country
- GVH Australia
- CING United States
- Employees
- GVH N/A
- CING N/A
- Industry
- GVH
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- CING Health Care
- Exchange
- GVH Nasdaq
- CING Nasdaq
- Market Cap
- GVH 21.3M
- CING 17.3M
- IPO Year
- GVH 2023
- CING 2021
- Fundamental
- Price
- GVH $0.08
- CING $4.42
- Analyst Decision
- GVH
- CING Strong Buy
- Analyst Count
- GVH 0
- CING 4
- Target Price
- GVH N/A
- CING $30.67
- AVG Volume (30 Days)
- GVH 86.8M
- CING 106.7K
- Earning Date
- GVH 02-12-2025
- CING 08-12-2025
- Dividend Yield
- GVH N/A
- CING N/A
- EPS Growth
- GVH 12.04
- CING N/A
- EPS
- GVH 0.09
- CING N/A
- Revenue
- GVH $16,540,178.00
- CING N/A
- Revenue This Year
- GVH N/A
- CING N/A
- Revenue Next Year
- GVH N/A
- CING N/A
- P/E Ratio
- GVH $0.82
- CING N/A
- Revenue Growth
- GVH N/A
- CING N/A
- 52 Week Low
- GVH $0.06
- CING $1.80
- 52 Week High
- GVH $1.82
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- GVH 21.87
- CING 57.09
- Support Level
- GVH $0.06
- CING $3.97
- Resistance Level
- GVH $0.10
- CING $4.26
- Average True Range (ATR)
- GVH 0.10
- CING 0.28
- MACD
- GVH -0.13
- CING 0.00
- Stochastic Oscillator
- GVH 1.27
- CING 65.82
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.